Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$481K Sell
5,860
-52
-0.9% -$4.1K 0.11% 136
2021
Q4
$453K Buy
5,912
+123
+2% +$9.8K 0.1% 144
2021
Q3
$486K Buy
+5,789
New +$440K 0.1% 146
2021
Q2
Sell
-4,738
Closed -$349K 141
2021
Q1
$349K Sell
4,738
-274
-5% -$20.2K 0.09% 153
2020
Q4
$391K Buy
5,012
+92
+2% +$7.04K 0.11% 137
2020
Q3
$389K Buy
4,920
+163
+3% +$12.8K 0.13% 126
2020
Q2
$351K Buy
4,757
+135
+3% +$10.2K 0.12% 127
2020
Q1
$339K Buy
4,622
+105
+2% +$8.25K 0.15% 112
2019
Q4
$392K Buy
4,517
+588
+15% +$48.3K 0.14% 125
2019
Q3
$316K Hold
3,929
0.11% 132
2019
Q2
$314K Hold
3,929
0.12% 138
2019
Q1
$312K Hold
3,929
0.11% 131
2018
Q4
$286K Buy
3,929
+9
+0.2% +$635 0.13% 129
2018
Q3
$265K Sell
3,920
-158
-4% -$10.1K 0.1% 129
2018
Q2
$236K Sell
4,078
-25,623
-86% -$1.45M 0.1% 128
2018
Q1
$1.54M Sell
29,701
-13,331
-31% -$720K 0.62% 31
2017
Q4
$2.31M Buy
43,032
+2,050
+5% +$114K 0.82% 26
2017
Q3
$2.5M Buy
40,982
+116
+0.3% +$7.03K 1.24% 17
2017
Q2
$2.5M Buy
+40,866
New +$2.49M 1.17% 18

Other funds holding MRK

Ferris Capital's MRK Position: Q1 2022 in Review

Ferris Capital reduced its Merck (MRK) stake by 0.88% in Q1 2022, selling an estimated $4.1K and leaving 5,860 shares worth $481K. The position accounts for 0.11% of the portfolio, ranked #136.

Ferris Capital first reported a position in MRK in Q2 2017 and has held it in 19 quarters since. The position peaked at $2.5M in Q3 2017. 2,953 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Ferris Capital held 5,860 shares of Merck worth $481K as of Q1 2022.
  • Ferris Capital sold 52 Merck shares in Q1 2022, an estimated $4.1K.
  • Merck made up 0.11% of Ferris Capital's portfolio in Q1 2022, its #136 holding.
  • Ferris Capital first reported a position in Merck in Q2 2017 and has held it in 19 quarters since.
  • Ferris Capital's Merck position peaked at $2.5M in Q3 2017.
  • 2,953 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Ferris Capital's 13F filing for Q1 2022, filed 13 May 2022.